Over at In the Pipeline, Derek Lowe's reaction to a new McKinsey report on pharma's return on investment elicits this succinct response: "Yikes." According to the report, ROI from small-molecule drug research has dropped from 12 percent in the late '90s to about 7.5 percent this decade.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.